DK150604C - Analogifremgangsmaade til fremstilling af calciumoxaprozin - Google Patents

Analogifremgangsmaade til fremstilling af calciumoxaprozin

Info

Publication number
DK150604C
DK150604C DK183582A DK183582A DK150604C DK 150604 C DK150604 C DK 150604C DK 183582 A DK183582 A DK 183582A DK 183582 A DK183582 A DK 183582A DK 150604 C DK150604 C DK 150604C
Authority
DK
Denmark
Prior art keywords
oxaprozine
preparing calcium
analogy procedure
oxaprozin
calcium
Prior art date
Application number
DK183582A
Other languages
English (en)
Other versions
DK150604B (da
DK183582A (da
Inventor
Ahmed Saeed Mughal
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of DK183582A publication Critical patent/DK183582A/da
Publication of DK150604B publication Critical patent/DK150604B/da
Application granted granted Critical
Publication of DK150604C publication Critical patent/DK150604C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK183582A 1981-04-28 1982-04-23 Analogifremgangsmaade til fremstilling af calciumoxaprozin DK150604C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8113074 1981-04-28
GB8113074 1981-04-28

Publications (3)

Publication Number Publication Date
DK183582A DK183582A (da) 1982-10-29
DK150604B DK150604B (da) 1987-04-13
DK150604C true DK150604C (da) 1987-12-07

Family

ID=10521427

Family Applications (1)

Application Number Title Priority Date Filing Date
DK183582A DK150604C (da) 1981-04-28 1982-04-23 Analogifremgangsmaade til fremstilling af calciumoxaprozin

Country Status (24)

Country Link
US (2) US4465838A (da)
EP (1) EP0063884B1 (da)
JP (1) JPS57181072A (da)
KR (1) KR880000871B1 (da)
AT (1) ATE14015T1 (da)
AU (1) AU544975B2 (da)
CA (1) CA1169867A (da)
CS (1) CS236674B2 (da)
DD (1) DD202017A5 (da)
DE (1) DE3264400D1 (da)
DK (1) DK150604C (da)
ES (1) ES511730A0 (da)
FI (1) FI71314C (da)
GR (1) GR75913B (da)
HU (1) HU185276B (da)
IE (1) IE52909B1 (da)
IL (1) IL65443A (da)
MY (1) MY8700599A (da)
NZ (1) NZ200247A (da)
PH (1) PH18053A (da)
PL (1) PL136322B1 (da)
PT (1) PT74794B (da)
ZA (1) ZA822355B (da)
ZW (1) ZW7482A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
CN1129429C (zh) * 1996-05-20 2003-12-03 G·D·瑟尔公司 钾、钠和三羟甲基氨基甲烷噁丙嗪盐药物配方
US7358254B2 (en) * 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
AU2006228869A1 (en) * 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
AR054336A1 (es) * 2005-03-30 2007-06-20 Astion Dev As Tratamiento de enfermedades dermatologicas y del prurito
EP2340296B1 (en) * 2008-08-26 2014-10-08 Dorf Ketal Chemicals (I) Private Limited A new additive for inhibiting acid corrosion and method of using the new additive
KR20140065862A (ko) * 2012-11-22 2014-05-30 에스케이케미칼주식회사 발포성 속붕해성 이매티닙 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles

Also Published As

Publication number Publication date
ZA822355B (en) 1983-11-30
IL65443A (en) 1985-04-30
ES8307230A1 (es) 1983-07-01
AU8237882A (en) 1982-11-04
ZW7482A1 (en) 1983-11-09
IE52909B1 (en) 1988-04-13
FI71314B (fi) 1986-09-09
CS236674B2 (en) 1985-05-15
IL65443A0 (en) 1982-07-30
DK150604B (da) 1987-04-13
DE3264400D1 (en) 1985-08-01
PT74794A (en) 1982-05-01
ES511730A0 (es) 1983-07-01
US4465838A (en) 1984-08-14
MY8700599A (en) 1987-12-31
GR75913B (da) 1984-08-02
FI71314C (fi) 1986-12-19
HU185276B (en) 1984-12-28
FI821324L (fi) 1982-10-29
PL236145A1 (da) 1982-12-06
DK183582A (da) 1982-10-29
US4532253A (en) 1985-07-30
JPS57181072A (en) 1982-11-08
IE820766L (en) 1982-10-28
KR830009772A (ko) 1983-12-23
PT74794B (en) 1983-11-07
NZ200247A (en) 1984-10-19
FI821324A0 (fi) 1982-04-15
EP0063884A1 (en) 1982-11-03
AU544975B2 (en) 1985-06-27
ATE14015T1 (de) 1985-07-15
JPH0261466B2 (da) 1990-12-20
PH18053A (en) 1985-03-18
KR880000871B1 (ko) 1988-05-28
EP0063884B1 (en) 1985-06-26
CA1169867A (en) 1984-06-26
PL136322B1 (en) 1986-02-28
DD202017A5 (de) 1983-08-24

Similar Documents

Publication Publication Date Title
ES503011A0 (es) Un procedimiento para la preparacion de una formulacion por-tadora de farmacos,biodegradable y magneticamente localiza- ble
ES513431A0 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
MX9102500A (es) Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES518180A0 (es) Procedimiento para la preparacion de bis-trihidroxibutil-amidas de acidos 2,4,6-triyodoaminoisoftalicos, hidroxietiladas en n.
DE3382112D1 (de) Pharmazeutische zusammensetzung.
DK267979A (da) Fremgangsmaade til fremstilling af aryloxypropanolaminer
DK150604C (da) Analogifremgangsmaade til fremstilling af calciumoxaprozin
IT7920235A0 (it) Composizione termoplastica, particolarmente per ingessature esimili applicazioni ortopediche.
ES510730A0 (es) "procedimiento para la preparacion de (2,2')-disulfuros de ditiazolilo".
ES509608A0 (es) Procedimiento para la preparacion de una composicion de lavado a base de peracidos y compuestos yoduro.
ES509761A0 (es) "procedimiento para la preparacion de 1,2 benzisoxazoloxietilaminas".
ES511577A0 (es) Procedimiento para la preparacion del heteropolisacarido s-198.
ES513429A0 (es) "un procedimiento para la preparacion de una composicion nematocida".
NO158299C (no) Analogifremgangsmaate for fremstilling av 17, 18-dehydro-apovincaminol-l-3', 4', 5'-trimethoxy-benzoat.
ES514224A0 (es) "procedimiento para la preparacion de 2,4-diamino-(3,5-dimetoxi-4-metoxietoxibenzil)-pirimidina".
NO822534L (no) Oxotienobenzooksepiner, fremgangsmaate til deres fremstilling og deres anvendelse som legemiddel
NO156863B (no) Fremgangsmaate til fremstilling av 1,2-dikloretan.
ES518341A0 (es) Procedimiento para la preparacion del 7-metilo-3-metileno-7-octeno-1-ilo-propionato.
ES509341A0 (es) Un procedimiento para la produccion de formulaciones veterinarias para uso intramamario.
ES516069A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
ES509720A0 (es) "procedimiento para la preparacion de 1,2-dicloroetano".
ES515054A0 (es) "procedimiento para la preparacion de 2-amino-5-mercapto-1,3,4-tiadiazoles".
ES515801A0 (es) "procedimiento para la preparacion de derivados de 1,2,3-tiadiazol-5-il-urea".
NO882000D0 (no) Fremgangsmaate til fremstilling av ren dimetyleter.
ES513331A0 (es) "procedimiento para la preparacion de 3,4,5-trimetoxibenzoato de 2-(4-isobutilfenil)propanol-1".

Legal Events

Date Code Title Description
PUP Patent expired